IRF8 induces senescence of lung cancer cells to exert its tumor suppressive function

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Lung cancer is a leading cause of cancer mortality globally.
• Systematic identification of tumor suppressor genes in lung cancer is crucial.
• Interferon regulatory factor 8 (IRF8) is a transcription factor within the IRF family.

Purpose of the Study:

• To identify and characterize novel tumor suppressor genes in lung cancer.
• To investigate the role of IRF8 as a potential tumor suppressor in non-small cell lung cancer (NSCLC).

Main Methods:

• Analysis of IRF8 expression in lung tumor tissues and correlation with patient prognosis.
• In vitro studies assessing the effects of ectopic IRF8 expression on NSCLC cell proliferation.
• In vivo studies using a genetically engineered mouse model (GEMM) and xenograft models to evaluate IRF8's impact on tumorigenesis.
• Mechanistic studies investigating IRF8's downstream signaling pathways, including AKT and P27.

Main Results:

• IRF8 expression is frequently reduced in lung tumors and linked to poorer NSCLC patient outcomes.
• Ectopic IRF8 expression inhibited NSCLC cell proliferation in vitro and tumor growth in vivo.
• Forced IRF8 expression via viral vectors suppressed lung tumorigenesis in a GEMM.
• IRF8 was found to inhibit AKT signaling and promote P27 accumulation, leading to cancer cell senescence.
• Ectopic IRF8 expression induced regression of lung cancer nodules in a xenograft model.

Conclusions:

• IRF8 functions as a potent lung tumor suppressor gene.
• Reduced IRF8 expression is associated with adverse prognosis in NSCLC patients.
• IRF8 represents a potential therapeutic target for NSCLC intervention.